Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SCANDINAVIAN BIOPHARMA HOLDING AB
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-09-25 to 2026-09-30
Current total value of award: $51663681.78
Description: THIS REQUIREMENT IS FOR THE RESEARCH AND PRODUCTION OF AN ENTEROTOXIGENIC E. COLI VACCINE TO HELP REDUCE WARFIGHTER DOWN TIME WHEN SERVING IN THEATRE.